GUIDANCE - Unknown Company - FDA Guidance: Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency: Guidance for Industry and Food and Drug Administration Staff | Global Key Solutions | Global Key Solutions